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Background Tendinopathy is often a chronic condition.
The mechanisms behind persistent tendon pain are not
yet fully understood. It is unknown whether, similar to
other persistent pain states, central pain mechanisms
contribute to ongoing tendon pain.
Aim We investigated the presence of altered central
pain processing in Achilles tendinopathy by assessing the
conditioned pain modulation (CPM) effect in people with
and without Achilles tendinopathy.
Methods 20 people with Achilles tendinopathy and 23
healthy volunteers participated in this cross-sectional
study. CPM was assessed by the cold pressor test. The
pressure pain threshold (PPT) was recorded over the
Achilles tendon before and during immersion of the
participant’s hand into cold water. The CPM effect was
quantified as the absolute difference in PPT before and
during the cold pressor test.
Results An increase in PPT was observed in the Achilles
tendinopathy and control group during the cold pressor
test (p<0.001). However, the CPM effect was stronger in
the control group (mean difference=160.5 kPa,
SD=84.9 kPa) compared to the Achilles tendinopathy
group (mean difference=36.4 kPa, SD=68.1 kPa;
p<0.001).
Summary We report a reduced conditioned pain
modulation effect in people with Achilles tendinopathy
compared to people without Achilles tendinopathy. A
reduced conditioned pain modulation effect reflects altered
central pain processing which is believed to contribute to
the persistence of pain in other conditions. Altered central
pain processing may also be an important factor in
persistent tendon pain that has traditionally been regarded
to be dominated by peripheral mechanisms.
INTRODUCTION
Tendinopathy is a generic term used to describe
tendon pathologies that typically manifest in pain,
swelling and dysfunction.1 Despite best available
management, tendon pain often becomes
chronic.2 3 Furthermore, the mechanisms under-
lying persistent tendon pain are not yet fully
understood.
Tendinopathy has traditionally been viewed as a
peripheral disorder confined to the tendon itself.
However, recent evidence suggests other possible
contributors to the persistence of tendon pain.4–8
Many chronic pain conditions share a number of
typical features, such as hyperalgesia/allodynia,9 10
widespread pain11 12 and reduced endogenous pain
modulation.10 13 In line with these presentations,
various tendinopathies are characterised by mech-
anical hyperalgesia,14 15 pinprick allodynia and
increased vibration disappearance thresholds.16 In
contrast, widespread pain is not a common clinical
presentation of tendinopathy.5 17 18 Yet, bilateral
symptoms (including sensory and motor deficits)
are often reported.3 6 14 Up to now, altered central
pain modulation (CPM) mechanisms have received
little research attention in people with tendon
pathology.
Endogenous pain modulation is governed by the
central nervous system via facilitatory and inhibi-
tory mechanisms. CPM testing paradigms are used
to examine the efficacy of descending pain modula-
tory pathways.19 In this experimental approach, the
application of a noxious ‘conditioning’ stimulus
typically results in pain inhibition for a subsequent
testing stimulus. CPM is, therefore, quantified as
the change in the intensity necessary to evoke pain
(or pain intensity) of the testing stimulus before
and during the application of the conditioning
stimulus.20 Persistent pain may reflect a possible
dysfunction in the inhibitory circuits21 which has
been evident in a plethora of chronic pain condi-
tions such as fibromyalgia,22 irritable bowel syn-
drome,23 pancreatitis,24 tension type headache,25
temporomandibular disorders,23 osteoarthritis26
and low back pain.27 Whether chronic tendon pain
is associated with similar deficits in central pain
modulatory mechanisms is yet to be investigated.
Therefore, the aim of this study was to examine the
efficacy of CPM in people with chronic Achilles





People with and without Achilles tendinopathy
were eligible to participate. Participants were
recruited via print and social media advertisements
from October 2014 to February 2015 they had to
be actively engaged in running activities at the
period of testing. All volunteers with pain over the
Achilles tendon region underwent a patient inter-
view and clinical examination. The diagnostic cri-
teria for Achilles tendinopathy included a
characteristic history of activity-related pain and
tenderness on tendon palpation.15 28 Participants
with Achilles tendinopathy were included if they
presented with pain in the Achilles tendon for at
least 3 months prior to testing. Participants with
any other medical condition or musculoskeletal dis-
order in the preceding 6 months that lasted for
more than 1 week or for which treatment was
sought were excluded. Further exclusion criteria
were the presence of systemic disorders,
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cardiovascular or neurological problems, fibromyalgia and any
medication usage.
Thirty volunteers with pain over the Achilles tendinopathy
region agreed to participate, but 10 did not meet the criteria (9
were excluded because they did not have Achilles tendinopathy;
1 patient with Achilles tendinopathy experienced symptoms for
less than 3 months). In addition, 26 symptom-free runners
without Achilles tendinopathy were recruited from the same
population, using the same recruitment strategies.
All participants completed the Victorian Institute of Sports
Assessment—Achilles Questionnaire (VISA-A)29 and the 21-item
activities of daily living (ADL) subscale of the Foot and Ankle
Ability Measure (FAAM).30 Additionally, the participants from
the Achilles tendinopathy group were asked to draw the areas
where they experienced pain on a lower limb chart.28
The study was approved by the local ethics committee of the
Department of Human Movement Sciences of VU University,
Amsterdam, the Netherlands (Reference: ECB 2014–58). It was
conducted according to the Declaration of Helsinki and all par-
ticipants signed an informed consent prior to their
participation.
CPM testing protocol
To explore CPM, the cold pressor test was used as the condi-
tioning stimulus and the pressure pain threshold (PPT) as the
test stimulus.19 20 Participants submerged their hand contralat-
eral to their affected ankle (or the most affected in case of bilat-
eral Achilles tendinopathy) in a container with cold water
(approximately 9° Celsius). Healthy volunteers immersed their
dominant hand. Continuous circulation of the water in the con-
tainer was implemented in order to prevent an increase in tem-
perature around the hand.31 The water temperature was
monitored by a thermometer with a digital display (resolution:
0.1°C). The participants placed their hand in the water up to
the level of the wrist and they were instructed to keep their
fingers spread. They were asked to rate their perceived hand
pain on a 0 (‘no pain’) to 10 (‘worst imaginable pain’) numerical
pain rating scale (NPRS). The CPM assessment began as soon as
a score of 5 was reached. When required, ice was added to the
water in order to maintain a minimum pain score of 4 on the
NPRS during the experiment.
The PPT measurements were performed using a digital alg-
ometer (Type II, Somedic AB, Stockholm, Sweden). The partici-
pants were placed prone on a treatment plinth with their feet
against the wall ensuring an ankle position of 0°. The assessment
site was the most painful location of the Achilles tendon as
determined by manual palpation.32 For the control group, the
point of pressure application was the mid-portion of the
Achilles tendon (approximately 2–3 cm proximal to the inser-
tion). The probe was placed perpendicular to the skin and the
pressure was applied through a 1 cm2 rubber plate at a constant
rate of 40 kPa/s. The participants were instructed to press a
button as soon as the applied pressure was perceived as painful.
Three consecutive trials with 30 s intervals were performed
before and during the application of the conditioning stimulus.
If the difference in consecutive PPTs reached more than
100 kPa, the procedure was repeated until three PPTs would
differ by less than 100 kPa within a maximum of five measure-
ments in total. The mean score of the three trials with the least
variance was calculated and used for further analysis. This
method showed excellent intra-rater reliability (Intraclass
Correlation Coefficient (ICC(2,1)): 0.96; 95% CI 0.88 to 0.99;
SE of Measurement (SEM): 8.74 kPa; Minimum Detectable
Change (MDC): 24.2 kPa) in a prior pilot study on 12 healthy
volunteers.
To familiarise the participants with the PPT measurements,
PPTs were performed over the thenar eminence of the dominant
hand and over the Achilles tendon contralateral to the tested
ankle before the actual experiment started. All experiments took
place in the Vrije University of Amsterdam, Amsterdam, the
Netherlands.
Statistical analysis
The characteristics of the group with and without Achilles tendi-
nopathy were compared with independent t tests, given a
normal distribution of the data. Independent t tests were also
used to examine potential differences between groups for the
water temperature and the intensity of the induced hand pain
during cold pressor test. For ordinal or non-normally distributed
data, the equivalent non-parametric test (Mann–Whitney U) was
performed. Normality was checked by visual inspection of the
q–q plot, the box plot of the data, and a Shapiro-Wilks test.
To determine whether there was a difference in CPM
responses between the Achilles tendinopathy and the control
group, PPTs were investigated in a 2×2 (Time (before and
during the cold pressor test)×Group (Achilles tendinopathy and
control group)) repeated-measures analysis of variance
(ANOVA). The normality and homogeneity of variance of the
data were examined prior to the test. There were no violations
of these assumptions. Any Group×Time interaction was clari-
fied by examining the difference in the CPM effect (quantified
as the difference in PPT values before and during cold pressor
test) between the groups with an independent t test.
Given a non-normal distribution, Spearman correlation coeffi-
cients (r) were calculated to explore whether the pain severity
(NPRS), symptom duration, functional limitation (FAAM) and
Achilles tendinopathy severity (VISA-A) were related to the
CPM response in the Achilles tendinopathy group.
RESULTS
Three healthy participants were excluded from the analysis (two
participants did not maintain the minimum required score of 4
on the NPRS during the cold pressor test; one participant
reported no pain during pressure application over the Achilles
tendon). Figure 1 visualises the pain location as reported by the
Achilles tendinopathy group. The characteristics of all partici-
pants who completed the experiment are shown in table 1. The
Achilles tendinopathy group was on an average older than the
control group (mean difference 6.8 years), yet the difference did
not reach statistical significance (95% CI (−14.68 to 1.18)). The
amount of running and cross-training per week was not signifi-
cantly different between the two groups. The outcomes of
FAAM and VISA-A were significantly lower in patients com-
pared to healthy participants. The PPT on the thenar eminence
did not differ significantly between the groups (mean differ-
ence=35.1, t(41)=1, p=0.33, 95% CI (−37.3 to 107.6)).
Conditioned pain modulation
During the cold pressor test, the water temperature was similar
for both the Achilles tendinopathy and control group (approxi-
mately 9°C). The level of induced hand pain was slightly higher
for people with Achilles tendinopathy than for healthy partici-
pants, yet the difference was not statistically significant (mean
difference=0.7, 95% CI (−1.5 to 0.2); table 2).
There was a significant main effect for time (F(1,41)=68.93,
p<0.001, h2r ¼ 0:63) and an interaction with the group
(F(1,41)=27.36, p<0.001, h2r ¼ 0:4), indicating that the
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change in PPT during the cold pressor test was different for
both groups. The CPM effect for the Achilles tendinopathy
group was significantly lower than for the control group (mean
difference=124.1 kPa, t(41)=5.2, 95% CI (76.2 to 192)). The
CPM responses are illustrated in table 2.
Correlations
No significant correlations between pain severity experienced
the week prior to the test (NPRS) (r=0.19; p=0.427), duration
of symptoms (r=−0.41; p=0.07), FAAM score (r=0.22;
p=0.35) or the VISA-A score (r=0.02; p=0.95) and the CPM
effect were identified.
DISCUSSION
We investigated differences in central pain processing between
people with Achilles tendinopathy and healthy individuals.
There was a significantly smaller CPM effect exhibited during
the cold pressor test in the Achilles tendinopathy group com-
pared to the control group. This indicates that central pain mod-
ulatory processes are altered in people with Achilles
tendinopathy.
CPM and chronic pain
CPM is a phenomenon that reflects the activity of the descend-
ing pain modulation system.20 33 A deficit in its function has been reported in a variety of clinical conditions associated with
chronic pain.34–36 The results of this study reveal a reduced
CPM effect in people with Achilles tendinopathy. As no previ-
ous studies have investigated CPM in a tendinopathy, compari-
sons with the present study are not yet possible. Nonetheless,
our findings provide evidence that people with Achilles tendino-
pathy share similar changes in central pain modulation mechan-
isms as do chronic pain patients with fibromyalgia,22 37 irritable
bowel syndrome,23 38 39 temporomandibular disorders,23 40
whiplash-associated disorders,41 42 tension type headache,25 43 44
osteoarthritis26 45 and low back pain.27 Such changes have been
suggested to contribute to the development of central sensitisa-
tion9 46–48 and chronicity of pain.49 50 Indeed, most of the
aforementioned conditions are expected to exhibit signs of
central sensitisation.11 26 51–58 Whether this is also the case in
people with Achilles tendinopathy remains to be investigated in
future research. Nonetheless, the reduced CPM effect in people
with Achilles tendinopathy, as observed in this study, suggests a
role of altered central pain mechanisms and may reveal a factor
contributing to chronic tendon pain.
It is a novel and interesting finding that CPM is reduced in
people with Achilles tendinopathy. Tendinopathy seems a par-
ticular chronic pain state in which tendon pain is provoked
Figure 1 Area of pain for the people with Achilles tendinopathy.
Darker colours represent a larger number of participants reporting pain
the corresponding area. Regardless of whether the left or right Achilles
tendon was affected, the locations are summarised on a diagram of the
right ankle (ie, locations on the left side were mirrored).
Table 1 Characteristics (mean (SD)) of the Achilles tendinopathy




tendinopathy (N=20) p Value
Age (years) 36.2 (12.3) 42.9 (13.5) 0.09
Gender (male/female) 16/7 16/4 –
Body mass index 21.9 (2.5) 23.4 (2.7) 0.11
Symptom duration (months) NA 21.8 (26.1) –
Side of symptoms (unilateral/
bilateral)
NA 11/9 –
NRPS (past week) NA 3.7 (1.9) –
VISA-A questionnaire 99.8 (0.9) 71.6 (15.8) <0.001
FAAM questionnaire 99.8 (0.5) 90.5 (10.7) <0.001
Running (km/week)* 30.0 (33) 27.5 (45) 0.11
Cross-training (hours/week) 2.4 (2.6) 1.7 (1.7) 0.51
PPT thenar (kPa) 372.5
(107.7)
337.4 (127.5) 0.33
FAAM, Functional Ankle Ability Measure; Km, kilometres; NA, not applicable; NPRS,
Numerical Pain Rating Scale; PPT, pain pressure threshold; VISA-A, Victorian Institute
of Sport Assessment-Achilles.
*Data are presented as Median (IQR).




tendinopathy (N=20) p Values*
Achilles tendon PPT (kPa)†
Before cold pressor test 671.4 (215.7) 253 (80.5) <0.001
During cold pressor test 831.9 (213.3) 289.4 (114.3) <0.001
CPM effect (kPa) 160.5 (84.9) 36.4 (68.1) <0.001
Water temperature (°C) 9.0 (0.9) 9.1 (0.8) 0.73
NPRS during cold pressor test 6.2 (1.3) 6.9 (1.6) 0.15
*p Values correspond to independent t tests.
†Contralateral to the dominant hand for the control group and the (most) affected for
the Achilles tendinopathy group.
°C, degrees Celsius; CPM, conditioned pain modulation; kPa, kilopascal; NRPS,
Numerical Pain Rating Scale.
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during loading and subsides once the load has been removed.5
Moreover, unlike other chronic pain conditions, Achilles tendi-
nopathy is not accompanied by great limitations in physical
functioning or ADLs. Particularly in the recruited Achilles tendi-
nopathy group, despite the long mean symptom duration
(≈2 years), pain intensity was moderate (≈4 on the NPRS) and
the activity level similar to the control group. In contrast to
what has been reported so far in the literature,59 in the present
study the CPM effect was not correlated with the functional
ability or the activity level of the patient group.
Central versus local mechanisms
Of particular importance in interpreting the altered CPM
response may be the net influences of local and central pain
mechanisms. It has been argued that local neural and inflamma-
tory processes may conceal endogenous analgesia.60 61
Sustained peripheral nociceptive activity from the tendon tissue
(see Rio et al5 for a review) may sensitise nociceptive neurons in
the dorsal horn of the spinal cord9 increasing their excitability,
thus counteracting the effects of descending inhibition. In two
studies in people with knee and hip osteoarthritis, the CPM
effect was weakened before but not after surgery, implying that
the reduced CPM was the result of ongoing nociceptive activ-
ity.45 62 Although inflammatory mediators are not always
expressed in tendinopathy,5 63 it is possible that the observed
reduction in the CPM effect is the manifestation of both periph-
eral and central pain mechanisms rather than central changes
alone.
Methodological variability with regards to CPM testing loca-
tion has been noted in the literature. Attenuated CPM in condi-
tions such as irritable bowel syndrome, tension type headache
and pancreatitis has been demonstrated at pain-free sites,23–25 38
whereas in temporomandibular disorders and osteoarthritis
reductions were found only at the painful or intrasegmental
areas.26 40 45 The syllogism behind testing CPM at a pain-free
or intact tissue is based on the fact that CPM is regarded as a
systemic rather than a localised phenomenon.60 Hence, a CPM
reduction exhibited in a pain-free area would be indicative of a
limitation of an individual’s endogenous analgesic capacity.
Moreover, as speculated above, a reduction in CPM in the
affected tissue could be conveyed by both peripheral and central
pain mechanisms. On the other hand, the absence of a CPM
reduction in an area remote to the painful site does not exclude
a possible contribution of central pain modulatory processes to
the ongoing pain. The idea that a change in descending modula-
tion will be evident in any area remote to the injured or painful
site features a static nature in a rather dynamic phenomenon.36
This raises questions regarding the choice of the most appropri-
ate testing location which would be anatomically close to—yet
sufficiently remote from—the painful region. The design of the
present study did not allow for a comparison of the CPM at the
painful versus a pain-free site. Comparison of the CPM effect as
elicited from affected versus unaffected tissues would have a
great potential in further enhancing our understanding of
tendon pain pathophysiology and warrants future research.
Is weaker conditioned pain modulation ‘dysfunctional’?
Another point that merits attention is the label ‘dysfunctional’
that is given to CPM when found to be different between
patient and healthy groups. Rationalising CPM teleologically by
the speculative but widely accepted notion that pain acts as a
warning system for danger or threat, the reduced CPM response
pattern seen in patient populations might reflect an adaptive
mechanism with the purpose to protect the painful area. For
such an adaptation to be functional, the assumption that a
threat is implied to the body is required. It is possible that the
reduced CPM effect in the Achilles tendinopathy group, as
observed in this study, is the expression of a dynamic and flex-
ible pain modulation process in the presence of increased affer-
ent nociceptive input warning for tissue damage. However, this
view is confronted by the common disassociation of tissue
damage and pain.64–67
CONCLUSION
Although the pain in tendinopathy is generally considered to be
driven by peripheral mechanisms, the findings of this study
reveal that people with Achilles tendinopathy modulate pain
centrally in a different way than healthy people. Such differ-
ences are evident in a variety of chronic pain conditions and
have been suggested to contribute to the chronicity of pain.
Thus, the reduced CPM as observed in people with Achilles ten-
dinopathy may promote ongoing tendon pain.
What are the findings?
▸ Pressure pain threshold testing over the Achilles tendon
revealed that the conditioned pain modulation effect is
reduced in people with Achilles tendinopathy.
▸ The findings indicate that besides peripheral mechanisms,
altered central pain processing also plays a role in persistent
Achilles tendinopathy.
▸ The reduction in conditioned pain modulation in people with
Achilles tendinopathy was not correlated with the severity of
Achilles tendinopathy (VISA-A), functional limitations
(FAAM), and activity levels (amount of running).
How might it impact on clinical practice in the future?
▸ If altered central pain modulation in people with Achilles
tendinopathy can be substantiated in future studies, the
clinical examination for people with Achilles tendinopathy
might have to incorporate assessment techniques to identify
all relevant contributing pain mechanisms.
▸ If future research confirms altered central pain modulation in
people with Achilles tendinopathy, it would be logical to
explore drug therapy and treatment modalities that target
the central nervous system in people with Achilles
tendinopathy.
▸ Considering the presence of altered conditioned pain
modulation effects in people with Achilles tendinopathy,
similar findings in patients with chronic and widespread
pain conditions, such as fibromyalgia and chronic fatigue
syndrome, may need to be reinterpreted.
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